OpenSpecimen moves disease study forward at the biobank

Posted by bob on Mar 16, 2015 2:52 AM EDT
Opensource.com; By Srikanth Adiga 		Mail this story
Print this story

Access to high-quality human biospecimens such as blood, saliva, plasma, DNA, and RNA is integral to developing a better understanding of diseases and advancing molecular technologies, clinical trial research, personalized medicine research, and clinical practice.

Full Story

  Nav
» Read more about: Story Type: Editorial; Groups: Community, Standards

« Return to the newswire homepage

This topic does not have any threads posted yet!

You cannot post until you login.